MarketPeel
EVP R&D, Chief Medical Officer
Thu, Feb 13, 2025
Feb 13
exercised or converted securities in ALKS
35,586 shares @ $24.59
Increased holdings by +21.30%
Net across this filing: -3.30% (-5,725 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-3.05%
1M-8.62%
3M+29.40%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback